Press Releases

Rheonix to Attend International Strategy and Investment Group’s MedTools and Outsourcing Investor Forum

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will attend the eighth annual International Strategy and Investment (ISI) Group’s MedTools and Outsourcing Investor Forum. The forum will take place Dec. 3-4 at the Boston Harbor Hotel, where leading companies from the life science tools, diagnostics and contract research organization (CRO) markets will have the opportunity to meet with key institutional investors. “The MedTools and Outsourcing Investor… Read More »

Most Innovative Cities-Ithaca, Featuring Greg Galvin, Ithaca Tech Power

It may not be Silicon Valley or New York City -- but Ithaca, N.Y., is working hard to position itself as a startup hub. The city is home to three colleges, including Cornell University, which has heavily invested in fostering bright, entrepreneurial minds. The university offers credits for students who want to take their startups to the next level, and introduced a new program to help students turn their technology designs into… Read More »

Rheonix to Automate FFPE Tissue Samples for Next Generation Sequencing and Other Advanced Analytical Systems

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted patent 8,852,919 “Microfluidic Apparatus, Method, and Applications” for its automated molecular system, the EncompassMDx™. This recent patent will help researchers and clinicians analyze tissue samples preserved in paraffin more efficiently, at a lower cost and with higher processing throughput. The ‘919 patent automates a liquid-liquid extraction process that easily removes paraffin from preserved tissue samples… Read More »

Rheonix to Present at Inaugural BTIG Emerging Technologies in Healthcare Diagnostics Symposium

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, will be presenting at the inaugural BTIG Emerging Technologies in Healthcare Diagnostics symposium. Richard Montagna, Ph.D., senior vice president for Scientific and Clinical Affairs at Rheonix, will speak about genomic workflow innovation and discuss the company’s breakthrough innovation utilizing a proprietary liquid-liquid extraction methodology for automated preparation of paraffin-preserved tissue samples for nucleic acid analysis. Dr. Montagna’s comments… Read More »

Rheonix, Inc. to Give Keynote Lecture on Molecular Diagnostics

BUFFALO, N.Y.— The University at Buffalo’s New York State Center of Excellence in Bioinformatics & Life Sciences (CBLS) will host Rheonix, Inc., a molecular diagnostic company based in Ithaca, N.Y., to deliver September’s Life Sciences Commercialization Lecture. The lecture will take place on Sept. 18 from 4 to 5 p.m. in the Bruce A. Holm Commons area (2nd floor), at the CBLS, 701 Ellicott Street, Buffalo. Senior Vice President for Scientific and… Read More »

Rheonix Lectures in China on Its Innovative Molecular Platform

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, recently spoke at Beijing University of Chemical Technology, School of Information and Technology. Dr. Zongyuan Chen, senior research engineer at Rheonix, lectured on the in vitro diagnostics (IVD) market to an audience of 70 graduate students and faculty members and provided an in-depth look at Rheonix’s breakthrough platform, the EncompassMDx™. According to IVD Technology magazine, the U.S.… Read More »

Rheonix to Showcase Automated Molecular Diagnostics Technology at American Association for Clinical Chemistry Annual Meeting

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will address the need for access to critical advanced molecular testing, labor shortages that limit the availability of testing, and other obstacles laboratories face in adopting this technology at the American Association for Clinical Chemistry (AACC) Annual Meeting in Chicago, Illinois, July 27-31. Rheonix will display its Chemical and Reagent Device (CARD) and EncompassMDx™ molecular testing platform. The… Read More »

Food-Safety Testing Gets a Much-Needed Makeover

Food poisoning. The impact on consumers can range from an inconvenient bout of gastrointestinal discomfort to hospitalization or even death. Every year in the U.S., one in six people suffers a food-related illness. Foodborne pathogens were responsible for 3,000 deaths reported in the U.S. in 2013. To help protect consumers, food producers and manufacturers follow rules promulgated by the U.S. Food and Drug Administration (FDA) and test food for pathogens.… Read More »

Rheonix Receives Fast-Track Grant from National Institutes of Health to Simplify HIV Testing

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, has received a Small Business Innovation Research (SBIR) Phase I Fast-Track grant from the National Institutes of Health (NIH) to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen. The Rheonix system will simplify HIV testing and eliminate the need for multiple patient visits… Read More »

Rheonix Executive Named a Fellow of National Academy of Clinical Biochemistry

ITHACA, N.Y. — Richard A. Montagna, Ph.D., senior vice president for scientific and clinical affairs at Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been accepted as a Fellow of the National Academy of Clinical Biochemistry (NACB). Fellowship in NACB is open to members of the American Association of Clinical Chemistry (AACC) who are doctoral-level clinical scientists. Fellows must hold American Board of Clinical Chemistry or equivalent board… Read More »
Page 3 of 812345...Last »

Archives